Clinically, we observed selective overexpression of COX4I1 in patients with blood cancers (Figure 1D; GENT2 database),[11] indicating a potential involvement of COX4I1 in hematopoietic cancers. This evidence concerns the gene COX4I1 and hematopoietic and lymphoid system neoplasm.